IP Library Granted Patent US 8,202,553
Granted Patent B2
US 8,202,553 · App. 12/651,251 · Granted Jun 19, 2012

Methods and compositions for treating blood circulation disorders

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,202,553
App. No.
12/651,251
Granted
Jun 19, 2012
Kind
B2
Abstract

Methods for preparing improved Panax Notoginseng saponin fraction from a Sanchi extract and its use in pharmaceutical compositions for treating or preventing a blood circulation disorder.

Claims (6)

1. A method of treating optic nerve atrophy, macular degeneration or retinitis pigmentosa in a mammal in need thereof consisting essentially of administering to said mammal a therapeutically effective amount of an extract of Panax Notoginseng containing greater than 60% (wt/vol) of saponins.

2. The method of claim 1 , wherein the mammal comprises at least one member selected from the group consisting of human, horse, bird, cat, dog, rat, hamster, mouse, guinea pig, cow, and pig.

3. The method of claim 1 , wherein the therapeutically effective amount is formulated as a pharmaceutical composition comprising at least one member selected from the group consisting of a tablet, a capsule, a solution, a suspension, a dropping pill, an emulsion, a suppository, an enema, an injection formulation, and a dermal patch formulation.

4. The method of claim 1 , wherein the extract of Panax Notoginseng contains greater than 80% (wt/vol) of saponins.

5. The method of claim 1 , wherein the extract of Panax Notoginseng contains greater than 95% (wt/vol) of saponins.

6. The method of claim 1 , wherein the therapeutically effective amount comprises 200 mg to 500 mg of an extract of Panax Notoginseng comprising 60% to 99% (wt/vol) of saponins.

Assignments (2)
CHANGE OF NAME Recorded May 28, 2021
From: KUNMING SHENGHUO PHARMACEUTICAL (GROUP) CO., LTD.
To: CHINA RESOURCES KUNMING SHENGHUO PHARMACEUTICAL CO., LTD.
Reel/Frame 056423/0740 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2013
From: LAN, GUIHUA; CHEN, PENG; LAN, FENG; FANG, SONG
To: KUNMING SHENGHUO PHARMACEUTICAL (GROUP) CO., LTD.
Reel/Frame 030398/0797 →
Continuity (1)
Related Publication 20110160153A1 · Jun 30, 2011